Literature DB >> 31894478

MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV.

Jinfeng Wang1, Xin Zhang2, Hongyue Yao1, Yuan Le1, Wei Zhou1, Jing Li1, Lingling Lu1, Meixue Chen1, Xiang Li1.   

Abstract

Neuroblastoma (NB) is the most common extracranial solid tumor derived from neural crest in children. Recently, the role of miRNA has been studied extensively in the development of NB. Here, we investigated the clinical significance of microRNA-490-5p (miR-490-5p) in NB. A total of 72 pairs of NB tumor tissues and matched adjacent normal nerve tissues were collected from NB patients. The expression of miR-490-5p was significantly down-regulated in NB tissues and cell lines using quantitative real-time PCR. Using Pearson Chi-square test and Kaplan-Meier analysis, we found that significantly decreased miR-490-5p levels were correlated with INSS stage, lymph-node metastasis, and poor survival prognosis in NB patients. MiR-490-5p overexpression significantly suppressed cell proliferation migration, invasion, and induced cell cycle G0/G1 arrest and cell apoptosis in NB cell lines (SH-SY5Y and SK-N-SH) using CCK-8, flow cytometry, and transwell assays. Mechanistically, MYEOV was confirmed as a target gene of miR-490-5p by luciferase reporter assay. Furthermore, MYEOV knockdown imitated, while overexpression rescued the changes in the biological features of miR-490-5p on NB cells. Our results demonstrated for the first time that miR-490-5p functions as a tumor suppressor in NB by targeting MYEOV, which might provide novel approaches for the treatment of NB.

Entities:  

Keywords:  MYEOV; Neuroblastoma; Prognosis; Tumor suppressor; miR-490-5p

Mesh:

Substances:

Year:  2020        PMID: 31894478     DOI: 10.1007/s13577-019-00302-z

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  28 in total

Review 1.  miRNAs, cancer, and stem cell division.

Authors:  Carlo M Croce; George A Calin
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

2.  MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells.

Authors:  Bin Xu; Tangpeng Xu; Huali Liu; Qian Min; Shidong Wang; Qibin Song
Journal:  Pharmacology       Date:  2017-08-16       Impact factor: 2.547

3.  MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1.

Authors:  Weiqing Chen; Lijun Ye; Dengcheng Wen; Feihua Chen
Journal:  Pathol Oncol Res       Date:  2017-09-19       Impact factor: 3.201

4.  Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).

Authors:  J W Janssen; J W Vaandrager; T Heuser; A Jauch; P M Kluin; E Geelen; P L Bergsagel; W M Kuehl; H G Drexler; T Otsuki; C R Bartram; E Schuuring
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

5.  MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2.

Authors:  Garrett Lawlor; Peter P Doran; Padraic MacMathuna; David W Murray
Journal:  J Exp Clin Cancer Res       Date:  2010-06-22

6.  Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry.

Authors:  Alberto Garaventa; Stefano Parodi; Bruno De Bernardi; Daniela Dau; Carla Manzitti; Massimo Conte; Fiorina Casale; Elisabetta Viscardi; Maurizio Bianchi; Paolo D'Angelo; Giulio Andrea Zanazzo; Roberto Luksch; Claudio Favre; Angela Tamburini; Riccardo Haupt
Journal:  Eur J Cancer       Date:  2009-07-16       Impact factor: 9.162

7.  MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.

Authors:  Johannes W G Janssen; Marguerite Cuny; Béatrice Orsetti; Carmen Rodriguez; Hélène Vallés; Claus R Bartram; Ed Schuuring; Charles Theillet
Journal:  Int J Cancer       Date:  2002-12-20       Impact factor: 7.396

8.  Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.

Authors:  Katja Specht; Eugenia Haralambieva; Karin Bink; Marcus Kremer; Sonja Mandl-Weber; Ina Koch; Raju Tomer; Heinz Hofler; Ed Schuuring; Philip M Kluin; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2004-04-13       Impact factor: 22.113

9.  MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.

Authors:  Gongbin Lan; Luoyan Yang; Xubiao Xie; Longkai Peng; Yi Wang
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

10.  Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma.

Authors:  Jing Ma; Min Xu; Minzhi Yin; Jie Hong; Haoyan Chen; Yijin Gao; Chenjie Xie; Nan Shen; Song Gu; Xi Mo
Journal:  Front Oncol       Date:  2019-06-12       Impact factor: 6.244

View more
  2 in total

Review 1.  Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Mohammadreza Hajiesmaeili; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 2.  MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal?

Authors:  Yin Li; Dongmei Tian; Hao Chen; Yuanting Cai; Sang Chen; Shiwei Duan
Journal:  Oncol Lett       Date:  2021-07-22       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.